Status | Study |
Terminated |
Study Name: Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus Condition: Recurrent Uterine Sarcoma Uterine Carcinosarcoma Date: 2010-02-02 Interventions: Drug: temsirolimus Given IV Other Names: |
Completed |
Study Name: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors Condition: Mesenchymal Tumor Carcinosarcoma Date: 2008-12-30 Interventions: Drug: PegLiposomal Doxorubicin |
Completed |
Study Name: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma Condition: Uterine Carcinosarcoma Date: 2008-05-28 Interventions: Drug: paclitaxel Paclitaxel wi |
Completed |
Study Name: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors Condition: Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Ca Date: 2007-08-22 Interventions: Drug: bevacizumab Other Names: |
Completed |
Study Name: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer Condition: Advanced Ovarian Carcinoma Primary Peritoneal Carcinoma Ov Date: 2007-08-03 Interventions: Drug: Avastin Initial Treatment: |
Completed |
Study Name: Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus Condition: Mixed Tumor, Mullerian Date: 2007-07-16 Interventions: Drug: Carboplatin AUC 5 By Vei |
Completed |
Study Name: Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus Condition: Mixed Mullerian Tumors of the Uterus Date: 2007-05-17 Interventions: Drug: Gemcitabine Other Name: |
Completed |
Study Name: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer Condition: Recurrent Uterine Sarcoma Stage III Uterine Sarcoma Stage Date: 2005-10-12 Interventions: Drug: sorafenib tosylate Given orally Other Names: |
Completed |
Study Name: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer Condition: Recurrent Uterine Corpus Sarcoma Uterine Carcinosarcoma Date: 2005-06-13 Interventions: Drug: Gemcitabine Hydrochloride |
Completed |
Study Name: Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer Condition: Sarcoma Date: 2005-06-02 Interventions: Drug: carboplatin Drug: paclitaxel |